Angela Lamarca Selected Research

Angela Lamarca Research Topics

Disease

41	Neoplasms (Cancer) 04/2024 - 01/2012
23	Cholangiocarcinoma 04/2024 - 07/2012
19	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2024 - 09/2015
10	Adenocarcinoma 05/2022 - 07/2012
9	Neuroendocrine Tumors (Neuroendocrine Tumor) 02/2024 - 10/2016
8	Neoplasm Metastasis (Metastasis) 04/2024 - 09/2015
8	Hepatocellular Carcinoma (Hepatoma) 09/2023 - 01/2014
6	Gallbladder Neoplasms (Gallbladder Cancer) 01/2024 - 01/2018
6	Pancreatic Neoplasms (Pancreatic Cancer) 10/2023 - 03/2016
5	Neuroendocrine Carcinoma 12/2023 - 01/2019
5	Carcinoid Tumor (Carcinoid) 01/2020 - 12/2016
4	Disease Progression 01/2022 - 01/2021
3	Stomach Neoplasms (Stomach Cancer) 01/2024 - 01/2017
3	Fibrosis (Cirrhosis) 11/2023 - 01/2022
3	Frailty 01/2022 - 01/2020
2	Klatskin Tumor 05/2022 - 03/2022
2	Inflammation (Inflammations) 05/2022 - 01/2015
2	Hypertension (High Blood Pressure) 10/2021 - 01/2017
2	Diarrhea 10/2021 - 01/2019
2	Carcinoma (Carcinomatosis) 01/2021 - 09/2020
2	Exanthema (Rash) 08/2019 - 04/2017
2	Primitive Neuroectodermal Tumors (PNET) 01/2018 - 03/2016
1	Extranodal Extension 02/2024
1	Portal Hypertension 11/2023
1	Margins of Excision 05/2022
1	Lymphatic Metastasis 05/2022
1	Obesity 01/2022
1	Overweight 01/2022
1	Sclerosing Cholangitis 01/2022
1	Hepatitis 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Liver Diseases (Liver Disease) 01/2022
1	Lung Diseases (Lung Disease) 01/2022
1	Choledocholithiasis 01/2022
1	Fatigue 10/2021
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2021
1	Infections 01/2021
1	Acute Kidney Injury (Acute Renal Failure) 01/2021
1	Febrile Neutropenia 01/2021
1	Weight Loss (Weight Reduction) 12/2020
1	Aortitis 10/2020
1	Vasculitis (Vasculitides) 10/2020
1	Ovarian Neoplasms (Ovarian Cancer) 06/2020

Drug/Important Bio-Agent (IBA)

16	Biomarkers (Surrogate Marker)IBA 09/2023 - 01/2017
9	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 02/2024 - 10/2016
7	Gemcitabine FDA Link 04/2024 - 09/2015
6	Capecitabine (Xeloda)FDA Link 01/2021 - 07/2012
4	Cisplatin (Platino)FDA LinkGeneric 04/2024 - 09/2015
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021 - 07/2012
3	Somatostatin Receptors (Somatostatin Receptor)IBA 02/2024 - 01/2014
3	6-propylchromone-2-carboxylic acid (PCCA)IBA 05/2022 - 01/2022
3	folfirinoxIBA 05/2022 - 10/2020
3	Leucovorin (Folinic Acid)FDA Link 01/2021 - 01/2020
3	Fluorouracil (Carac)FDA LinkGeneric 01/2021 - 01/2020
3	Sorafenib (BAY 43-9006)FDA Link 12/2018 - 01/2014
2	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 02/2024 - 01/2018
2	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 12/2023 - 01/2020
2	SirtuinsIBA 07/2023 - 09/2021
2	Docetaxel (Taxotere)FDA Link 06/2023 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2015
2	Cell-Free Nucleic AcidsIBA 09/2021 - 12/2019
2	ivosidenibIBA 04/2021 - 01/2020
2	PlatinumIBA 01/2021 - 10/2020
2	Etoposide (VP 16)FDA LinkGeneric 01/2021 - 01/2019
2	Irinotecan (Camptosar)FDA LinkGeneric 10/2020 - 01/2020
2	Adenosine Monophosphate (AMP)IBA 09/2020 - 01/2018
2	Temozolomide (Temodar)FDA LinkGeneric 01/2020 - 01/2020
2	telotristat ethylIBA 01/2019 - 12/2016
2	ErbB Receptors (EGF Receptor)IBA 04/2017 - 01/2017
1	pembrolizumabIBA 04/2024
1	Peptides (Polypeptides)IBA 02/2024
1	ElementsIBA 11/2023
1	Immune Checkpoint InhibitorsIBA 09/2023
1	Fibrinogen (Factor I)FDA Link 01/2023
1	Everolimus FDA Link 01/2022
1	Oncostatin MIBA 12/2021
1	Oncostatin M Receptors (Oncostatin M Receptor)IBA 12/2021
1	lenvatinibIBA 10/2021
1	MicroRNAs (MicroRNA)IBA 09/2021
1	Investigational DrugsIBA 04/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Octreotide (Sandostatin)FDA LinkGeneric 01/2021
1	lanreotide (Somatuline)FDA Link 01/2021
1	APTIBA 01/2021
1	infigratinibIBA 10/2020
1	LigandsIBA 09/2020
1	Yttrium-90IBA 07/2020
1	NUC-1031IBA 06/2020
1	Nucleoside Transport Proteins (Nucleoside Transporter)IBA 06/2020

Therapy/Procedure

30	Therapeutics 01/2024 - 08/2013
28	Drug Therapy (Chemotherapy) 01/2024 - 07/2012
6	Precision Medicine 01/2024 - 01/2017
4	Immunotherapy 01/2024 - 09/2020
4	Radiotherapy 08/2023 - 08/2019
2	Palliative Care (Palliative Therapy) 10/2023 - 12/2020
2	Neoadjuvant Therapy 01/2022 - 08/2019
1	Radiofrequency Ablation 08/2023
1	Drug Tapering 10/2021
1	Aftercare (After-Treatment) 10/2021
1	Enzyme Replacement Therapy 10/2021